Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Radiotherapy for Stage T3 Rectal Cancer
NCT00145769Phase 3Completed
- Sponsor
- Trans-Tasman Radiation Oncology Group
- Start
- Jul 2001
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of fluorouracil in rectal cancer (2 arms), sponsored by Trans-Tasman Radiation Oncology Group. Primary endpoint: Local Recurrence Rate at 3 years. Started Jul 2001; status: completed.
02
Drugs
fluorouracil
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00145769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145769.